Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma |
Dana-Farber Cancer Institute / Cigall Kadoch, PhD |
'A' Award Grants |
2017 |
Massachusetts |
Identification and Characterization of Pathways Dysregulated by MMSET E1099K Mutation in Relapsed Pediatric Acute Lymphoblastic Leukemia and Their Role in Drug Resistance |
New York University School of Medicine / Joanna Pierro, DO |
Young Investigator Grants |
2017 |
New York |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML |
Children’s Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD |
Reach Grants |
2017 |
Wisconsin |
Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma |
Boston Children’s Hospital / Shuibin Lin, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Alternative Splicing in the Pathogenesis of Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD |
Innovation Grants |
2017 |
Pennsylvania |
Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish |
Dana-Farber Cancer Institute / Serine Avagyan, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children |
Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD/PhD |
Reach Grants |
2018 |
Washington |
Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia |
Harvard University / Nick van Gastel, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
MYC-driven Core Regulatory Circuits in Neuroblastoma |
Dana-Farber Cancer Institute / Mark Zimmerman, PhD |
Young Investigator Grants |
2018 |
Massachusetts |